<SEC-DOCUMENT>0002073679-26-000045-index.html : 20260407
<SEC-HEADER>0002073679-26-000045.hdr.sgml : 20260407
<ACCEPTANCE-DATETIME>20260407171251
ACCESSION NUMBER:		0002073679-26-000045
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20260407
DATE AS OF CHANGE:		20260407

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nasus Pharma Ltd
		CENTRAL INDEX KEY:			0002029039
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				516022712
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-95201
		FILM NUMBER:		26845696

	BUSINESS ADDRESS:	
		STREET 1:		29 HARAKEVET ST
		CITY:			TEL AVIV - YAFO
		STATE:			L3
		ZIP:			6618003
		BUSINESS PHONE:		972 54-255-3956

	MAIL ADDRESS:	
		STREET 1:		29 HARAKEVET ST
		CITY:			TEL AVIV - YAFO
		STATE:			L3
		ZIP:			6618003

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Funicular Funds, LP
		CENTRAL INDEX KEY:			0001937147
		ORGANIZATION NAME:           	
		EIN:				882460308
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G

	BUSINESS ADDRESS:	
		STREET 1:		2261 MARKET STREET
		STREET 2:		#4307
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94114
		BUSINESS PHONE:		4158571965

	MAIL ADDRESS:	
		STREET 1:		2261 MARKET STREET
		STREET 2:		#4307
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94114
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1
<SEQUENCE>2
<FILENAME>exhibita.pdf
<TEXT>
Document 2 - file: exhibita.pdf

</DOCUMENT>
</SEC-DOCUMENT>